Adenovirus-mediated expression of SSAT inhibits colorectal cancer cell growth in vitro

Acta Pharmacologica Sinica

Volumn 29, Issue 5, 2008, Pages 606-613

  Sun, Hui ^a   Liu, Bin ^a   Yang, Ya Pei ^a   Xu, Chun Xiao ^a   Yan, Yun Fei ^a   Wang, Wei ^a   Liu, Xian Xi ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adenovirus; Colorectal cancer; Spermidine spermine N1 acetyltransferase

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACYLTRANSFERASE; GREEN FLUORESCENT PROTEIN; POLYAMINE; SPERMIDINE; SPERMIDINE SPERMINE ACETYLTRANSFERASE; SPERMINE;

ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL STRAIN HEK293; CELL STRAIN HT29; COLORECTAL CANCER; CONTROLLED STUDY; EXPRESSION VECTOR; FLUORESCENCE MICROSCOPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; PLASMID; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VIRUS EXPRESSION; VIRUS RECOMBINANT; WESTERN BLOTTING;

EID: 42649090112     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00779.x     Document Type: Article

References (28)

1. 1 Porter CW, Regenass U, Bergeron RJ. In: Dowling RH, Folsch UR, Loser C, editors. Falk symposium on polyamines in the gastrointestinal tract ; Dordrecht, Netherlands: Kluwer Academic Publishers Group ; 1992. p 301–22.
2. 2 Auvinen M, Paasinen A, Andersson LC, Holtta E. Ornithine decarboxylase activity is critical for cell transformation. Nature 1992 ; 360: 355–8.
3. 3 Moshier JA, Dosescu J, Skunca M, Luk GD. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Cancer Res 1993 ; 53: 2618–22.
4. 4 Pegg AE, Xiong H, Feith DJ, Shantz LM. S ‐adenosylmethionine decarboxylase: structure, function and regulation by polyamines. Biochem Soc Trans 1998 ; 26: 580–6.
5. 5 Marton LJ, Pegg AE. Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 1995 ; 35: 55–91.
6. 6 Glikman P, Vegh I, Pollina MA, Mosto AH, Levy CM. Ornithine decarboxylase activity, prolactin blood levels, and estradiol and progesterone receptors in human breast cancer. Cancer 1987 ; 60: 2237–43.
7. 7 Upp JR, Saydjari R, Townsend CM, Singh P, Barranco SC, Thompson JC. Polyamine levels and gastrin receptors in colon cancers. Ann Surg 1988 ; 207: 662–9.
8. 8 Gerner EW, Meyskens FL. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 2004 ; 4: 781–92.
9. 9 Loser C, Folsch UR, Paprotny C, Creutzfeldt W. Polyamines in colorectal cancer. Evaluation of polyamine concentrations in the colon tissue, serum and urine of 50 patients with colorectal cancer. Cancer 1990 ; 65: 958–66.
10. 10 Higuchi CM, Wang W. Comodulation of cellular polyamines and proliferation: biomarker application to colorectal mucosa. J Cell Biochem 1995 ; 57: 256–61.
11. 11 Hu HY, Liu XX, Jiang CY, Zhang Y, Bian JF, Lu Y, et al. Cloning and expression of ornithine decarboxylase gene from human colorectal carcinoma. World J Gastroenterol 2003 ; 9: 714–6.
12. 12 Hu HY, Liu XX, Jiang CY, Lu Y, Liu SL, Bian JF, et al. Ornithine decarboxylase gene is overexpressed in colorectal carcinoma. World J Gastroenterol 2005 ; 11: 2244–8.
13. 13 Zhang B, Liu XX, Zhang Y, Jiang CY, Teng QS, Hu HY, et al. Adenovirus‐mediated expression of both antisense ODC and AdoMetDC inhibits colorectal cancer cell growth in vitro. Acta Pharmacol Sin 2006 ; 27: 353–9.
14. 14 Zhang B, Liu XX, Zhang Y, Jiang CY, Hu HY, Gong L, et al. Polyamine depletion by ODC‐AdoMetDC antisense adenovirus impairs human colorectal cancer growth and invasion in vitro and in vivo. J Gene Med 2006 ; 8: 980–9.
15. 15 Chi WL, Song XR, Jiang CY, Liu XX, Li WT, Wang XW. Lentiviral vector‐mediated downregulation of ornithine decarboxylase inhibits tumor cell growth in vitro and in vivo. Tumor Biol 2006 ; 27: 243–51.
16. 16 Vujcic S, Halmekyto M, Diegelman P, Gan G, Kramer DL, Janne J, et al. Effects of conditional overexpression of spermidine/spermine N 1 ‐acetyltransferase on polyamine pool dynamics, cell growth, and sensitivity to polyamine analogs. J Biol Chem 2000 ; 275: 38319–28.
17. 17 Wallace HM, Caslake R. Polyamines and colon cancer. Eur J Gastroenterol Hepatol 2001 ; 13: 1033–9.
18. 18 Casero RA, Pegg AE. Spermidine/spermine N 1 ‐acetyltransferase: the turning point in polyamine metabolism. FASEM J 1993 ; 7: 653–61.
19. 19 Seiler N. Functions of polyamine acetylation. Can J Physiol Pharmacol 1987 ; 65: 2024–35.
20. 20 Marton LJ, Pegg AE. Polyamines as targets for therapeutic intervention. Annu Rev Pharm 1995 ; 35: 55–91.
21. 21 Casero RA, Woster PM. Terminally alkylated polyamine analogues as chemotherapeutic agents. J Med Chem 2001 ; 44: 1–26.
22. 22 Martin ME, O'Brien TG, Fultz KE, Babbar N, Yerushalmi H, Qu N, et al. Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proc Natl Acad Sci USA 2003 ; 100: 7859–64.
23. 23 Babbar N, Gerner EW, Casero RA. Induction of spermidine/spermine N 1 ‐acetyltransferase (SSAT) by aspirin in Caco‐2 colon cancer cells. Biochem J 2006 ; 394: 317–24.
24. 24 Yi C, Huang Y, Guo ZY, Wang SR. Antitumor effect of cytosine deaminase/5‐fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma. Acta Pharmacol Sin 2005 ; 26: 629–34.
25. 25 Zhang SN, Yuan SZ, Zhu ZH, Wen ZF, Huang ZQ, Zeng ZY. Apoptosis induced by 5‐flucytosine in human pancreatic cancer cells genetically modified to express cytosine deaminase. Acta Pharmacol Sin 2000 ; 21: 655–9.
26. 26 Hu YC. Baculovirus as a highly efficient expression vector in insect and mammalian cells. Acta Pharmacol Sin 2005 ; 26: 405–16.
27. 27 Li L, He DL. Transfection of promyelocytic leukemia in retrovirus vector inhibits growth of human bladder cancer cells. Acta Pharmacol Sin 2005 ; 26: 610–5.
28. 28 Kanerva A, Hemminki A. Modified adenoviruses for cancer gene therapy. Int J Cancer 2004 ; 110: 475–80.